Redwood City, California -- Medical device company Autonomic Technologies has received $23 million in new equity venture capital, according to an SEC regulatory filing.
Autonomic is developing medical device technologies for the treatment of severe headache.
The company has received a CE mark approving the marketing of its ATI Neural Stimulation System for the treatment of cluster headache.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
A total of 23 investors participated in the offering.
CEO Niamh Pellegrini Has been with the company since April 2016 and previously was president, North America of Thoratec.